SHR-A1921 Combined With Bevacizumab in Triple-negative Breast Cancer With Brain Metastases
Clinical trial NCT06210438 · UNKNOWN
Trial details
- NCT number
- NCT06210438
- Sponsor
- Fudan University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-01
- Primary completion
- 2025-06-30
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.